Premium
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post‐menopausal women
Author(s) -
Varma T.R.,
Morsman John
Publication year - 1982
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(82)90018-2
Subject(s) - medicine , dydrogesterone , norgestrel , norethisterone , endocrinology , triglyceride , norethisterone acetate , adverse effect , menopause , progestin , estradiol valerate , estrogen , dose , dienogest , cholesterol , population , health services , research methodology , endometriosis , environmental health , family planning
A study of 240 post‐menopausal women receiving Dixarit (clonidine hydrochloride), Premarin (conjugated equine oestrogens), Harmogen (piperazine oestrone sulphate) and Progynova (oestradiol valerate) in two different dosages alone and in combination with progestational agents such as norethisterone acetate, dydrogesterone, and norgestrel for climacteric symptoms showed that there was no adverse effect on serum lipid levels. There was no significant change in the serum cholesterol and triglyceride levels during treatment with oestrogen replacement therapy.